Case Managers and Their Role in Improving Patient Outcomes in Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a rare, progressive lung disease that greatly impacts patients’ quality of life and diminishes life expectancy. Newer therapies slow lung function decline. These therapies are used in combination with oxygen supplementation, pulmonary rehabilitation, symptomatic treatment, and supportive care. Case managers and respiratory therapists need education on the new therapies and supportive care to educate and counsel patients with IPF, as well as optimize their care.

This text-based activity will educate case managers and registered respiratory therapists (RRT) on the current management of idiopathic pulmonary fibrosis (IPF) and newer therapies that may impact treatment paradigms and patient outcomes. In addition to text, this activity includes audio clips featuring faculty commentary and an ask-the-expert feature. The format is conducive to viewing online and on tablets and smartphones.

Upon completion of this activity, participants will be able to:
•Discuss the burden of IPF on patient quality of life over the disease course
•Evaluate the efficacy, tolerability, and safety data for pharmacotherapies for IPF
•Counsel IPF patients and their caregivers on supportive care and pharmacologic approaches
•Assist with comprehensive care plans and appropriate referral to specialists